Your browser doesn't support javascript.
loading
Results from a single arm, single stage phase II trial of trametinib and GSK2141795 in persistent or recurrent cervical cancer.
Liu, Joyce F; Gray, Kathryn P; Wright, Alexi A; Campos, Susana; Konstantinopoulos, Panagiotis A; Peralta, Ariana; MacNeill, Kimberley; Morrissey, Stephanie; Whalen, Christin; Dillon, Deborah; Matulonis, Ursula A.
Afiliação
  • Liu JF; Division of Gynecologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America. Electronic address: joyce_liu@dfci.harvard.edu.
  • Gray KP; Department of Data Science, Dana-Farber Cancer Institute Boston, MA, United States of America.
  • Wright AA; Division of Gynecologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.
  • Campos S; Division of Gynecologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.
  • Konstantinopoulos PA; Division of Gynecologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.
  • Peralta A; Division of Gynecologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.
  • MacNeill K; Division of Gynecologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.
  • Morrissey S; Division of Gynecologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.
  • Whalen C; Division of Gynecologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.
  • Dillon D; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States of America.
  • Matulonis UA; Division of Gynecologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.
Gynecol Oncol ; 154(1): 95-101, 2019 07.
Article em En | MEDLINE | ID: mdl-31118140
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Colo do Útero / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials Limite: Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Colo do Útero / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials Limite: Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos